Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 289

1.

Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction.

Fiorentino TV, Marini MA, Succurro E, Sciacqua A, Andreozzi F, Perticone F, Sesti G.

Oncotarget. 2017 Jun 19. doi: 10.18632/oncotarget.18572. [Epub ahead of print]

2.

Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals.

Andreozzi F, Mannino GC, Mancuso E, Spiga R, Perticone F, Sesti G.

PLoS One. 2017 Jun 21;12(6):e0179834. doi: 10.1371/journal.pone.0179834. eCollection 2017.

3.

Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity.

Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Perticone M, Sciacqua A, Perticone F, Sesti G.

Acta Diabetol. 2017 Jun 2. doi: 10.1007/s00592-017-1004-z. [Epub ahead of print]

PMID:
28577138
4.

Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials.

Monami M, Nreu B, Scatena A, Giannini S, Andreozzi F, Sesti G, Mannucci E.

J Endocrinol Invest. 2017 May 31. doi: 10.1007/s40618-017-0698-7. [Epub ahead of print]

PMID:
28569363
5.

Risk reclassification ability of uric acid for cardiovascular outcomes in essential hypertension.

Perticone M, Tripepi G, Maio R, Cimellaro A, Addesi D, Baggetta R, Sciacqua A, Sesti G, Perticone F.

Int J Cardiol. 2017 May 13. pii: S0167-5273(17)31307-4. doi: 10.1016/j.ijcard.2017.05.051. [Epub ahead of print]

PMID:
28528984
6.

Hemorheological alterations in adults with prediabetes identified by hemoglobin A1c levels.

Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Succurro E, Sciacqua A, Perticone F, Sesti G.

Nutr Metab Cardiovasc Dis. 2017 Apr 21. pii: S0939-4753(17)30064-9. doi: 10.1016/j.numecd.2017.04.001. [Epub ahead of print]

PMID:
28511905
7.

Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials.

Monami M, Zannoni S, Pala L, Silverii A, Andreozzi F, Sesti G, Mannucci E.

Int J Cardiol. 2017 Aug 1;240:414-421. doi: 10.1016/j.ijcard.2017.03.163. Epub 2017 May 5.

PMID:
28501352
8.

Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals.

Marini MA, Fiorentino TV, Succurro E, Pedace E, Andreozzi F, Sciacqua A, Perticone F, Sesti G.

PLoS One. 2017 Apr 20;12(4):e0175547. doi: 10.1371/journal.pone.0175547. eCollection 2017.

9.

A polymorphism at IGF1 locus is associated with anemia.

Marini MA, Mannino GC, Fiorentino TV, Andreozzi F, Perticone F, Sesti G.

Oncotarget. 2017 May 16;8(20):32398-32406. doi: 10.18632/oncotarget.16132.

10.

Uric Acid Is Associated With Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-κB Signaling Pathway in HepG2 Cells.

Spiga R, Marini MA, Mancuso E, Di Fatta C, Fuoco A, Perticone F, Andreozzi F, Mannino GC, Sesti G.

Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1241-1249. doi: 10.1161/ATVBAHA.117.309128. Epub 2017 Apr 13.

PMID:
28408375
11.

Mechanisms linking empagliflozin to cardiovascular and renal protection.

Perrone-Filardi P, Avogaro A, Bonora E, Colivicchi F, Fioretto P, Maggioni AP, Sesti G, Ferrannini E.

Int J Cardiol. 2017 Aug 15;241:450-456. doi: 10.1016/j.ijcard.2017.03.089. Epub 2017 Mar 23.

PMID:
28395981
12.

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators.

N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17.

PMID:
28304242
13.

Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study.

Bertolotti M, Franchi C, Rocchi MB, Miceli A, Libbra MV, Nobili A, Lancellotti G, Carulli L, Mussi C; REPOSI Investigators.

Drugs Aging. 2017 Apr;34(4):311-319. doi: 10.1007/s40266-017-0448-8.

PMID:
28299634
14.

Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials.

Monami M, Nreu B, Scatena A, Cresci B, Andreozzi F, Sesti G, Mannucci E.

Diabetes Obes Metab. 2017 Feb 28. doi: 10.1111/dom.12926. [Epub ahead of print]

PMID:
28244632
15.

[Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk factors and the cardiovascular system].

Fiorentino TV, Sesti G.

G Ital Cardiol (Rome). 2016 Dec;17(12 Suppl 2):13S-19. doi: 10.1714/2616.26911. Italian.

PMID:
28151517
16.

Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes.

Rizzo M, Rizvi AA, Sesti G.

Diabetes Obes Metab. 2017 May;19(5):613-614. doi: 10.1111/dom.12883. Epub 2017 Mar 2. No abstract available.

PMID:
28098425
17.

Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.

Palleria C, Leo A, Andreozzi F, Citraro R, Iannone M, Spiga R, Sesti G, Constanti A, De Sarro G, Arturi F, Russo E.

Behav Brain Res. 2017 Mar 15;321:157-169. doi: 10.1016/j.bbr.2017.01.004. Epub 2017 Jan 3.

PMID:
28062257
18.

Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.

Andreozzi F, Mannino GC, Perticone M, Perticone F, Sesti G.

Atherosclerosis. 2017 Jan;256:15-20. doi: 10.1016/j.atherosclerosis.2016.11.020. Epub 2016 Nov 17.

PMID:
27940375
19.

Liraglutide improves cardiac function in patients with type 2 diabetes and chronic heart failure.

Arturi F, Succurro E, Miceli S, Cloro C, Ruffo M, Maio R, Perticone M, Sesti G, Perticone F.

Endocrine. 2016 Nov 9. [Epub ahead of print]

PMID:
27830456
20.

One-Hour Postload Hyperglycemia Confers Higher Risk of Hepatic Steatosis to HbA1c-Defined Prediabetic Subjects.

Fiorentino TV, Andreozzi F, Mannino GC, Pedace E, Perticone M, Sciacqua A, Perticone F, Sesti G.

J Clin Endocrinol Metab. 2016 Nov;101(11):4030-4038. Epub 2016 Jul 26.

PMID:
27459528

Supplemental Content

Loading ...
Support Center